[1]Stewart WF, Ricci JA, Chee E. Lost productive time and cost due to common pain conditions in the US workforce . JAMA, 2003, 290(18):2443-2454.
[2]Choi KC, Kim JS, Kang BU. Changes in back pain after percutaneous endoscopic lumbar discectomy and annuloplasty for lumbar disc herniation: a prospective study . Pain Med, 2011, 12(11):1615-1621.
[3]Wu H, Xue R, Lu C. Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry. J Chromatogr B Analyt Technol Biomed Life,2009, 877:3111-3117.
[4]Urban MR, Fair JC, Etheington PJ. Electrochemical measurement of transport into scoliotic intervertebral discs in vivo using nitrous oxide tracer. Spine (Phila Pa 1976), 2001,26:984-990.
[5]Nicholson JK, Lindon JC, Holmes E.‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica, 1999, 29(11): 1181-1189.
[6]Monton MRN, Soga T. Metabolome analysis by Capillary Electrophoresis-Mass Spectrometry. Journal of Chromatography A, 2007, 1168: 237-246.
[7]Gou X, Tao Q, Feng Q. Urinary metabonomics characterization of liver fibrosis induced by CCl4 in rats and intervention effects of Xia Yu Xue Decoction. J Pharm Biomed Anal, 2013, 74:62-65.
[8]Gou X, Tao Q, Feng Q. Urine metabolic profile changes of CCl4-liver fibrosis in rats and intervention effects of Yi Guan Jian Decoction using metabonomic approach. BMC Complement Altern Med, 2013, 13:123-135.
[9]R J B Peters, A A M Stolker, J G J Mol. Trends Anal. Chem, 2010, 29(11):1250-1268.
[10]Pfirrmnann C W, Metzdorf A, Zanetti M. Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine, 2001, 26(17):1873-1878.
[11]Eriksson L, Antti H, Gottfries J. Using chemometrics for navigating in the large date sets of genomics, proteomics, and metabonomics(gpm). Anal Bioanal Chem, 2004, 380(3):419-429.
[12]Adams M A, Roughley P J. What is intervertebral disc degeneration, and what causes it?. Spine, 2006, 31(18): 2151-2161.
[13]Waddell G Low back pain: a twentieth century health care enigma. Spine, 1996, 21(24): 2820-2825.
[14]Nicholson JK, Lindon JC, Holmes E. ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica, 1999, 29(11): 1181-1189.
[15]Fiehn O, Kopka J, Dormann P. Metabolite profiling for plant functional genomics. Nat Biotechnol, 2000, 18(11): 1157-1161.
[16]Guowang Xu, Xin Lu, Shengli Yang. Advances in metabonomics. Journal of Chinese Academy of Medical Sciences, 2007, 29(6): 701-711.
[17]Zhehua Zhang, Huinan Ge. Progress of metabonomics in the diagnosis of digestive tract diseases. Journal of Qilu Medical Journal, 2014, 29(3):279-280.
[18]Fiehn O. Extending the breadth of metabolite profiling by gas chromatography coupled to mass spectrometry. Trends in Analytical Chemistry, 2008, 27(3): 261-269.
[19]F Hernandez, T Portoles, E Pitarch . Trends Ana1. Chem. , 2011, 30, (2):388-400.
[20]F Hernandez, T Portoles, E Pitarch . Mass Spectrom , 2009, 44(1):1-11.
[21]Goupille P, Malcom Ⅳ. Jayson, Jean-pierre Valat. Matrix metalloproteinases: the clue to intervertebral disc degeneration. Spine. 1998, 23:1612-1626.
[22]Grunhagen T, Wilde G, Soukane DM. Nutrient supply and intervertebral disc metabolism. J Bone Joint Surg Am. 2006, 88(Suppl 2):30-35.
[23]Dettmer K, Aronov PA, Hammock BD. Mass spectrometry-based metabolomics. Mass Spectrom Rev, 2007, 26(1): 51-78.
[24]Ackermann BL, Hale JE, Duffin KL. The role of mass spectrometry in biomarker discovery and measurement. Curr Drug Metab, 2006, 7(5): 525-539.
[25]Dunn WB, Ellis DI. Metabolomics: current analytical platforms and methodologies. Trac Trends Anal Chem, 2005, 24(4): 285-294.
[26]Hollywood K, Brison DR, Goodacre R. Metabolomics: current technologies and future trends. Proteomics, 2006, 6(17): 4716-4723.
[27]Dunn WB, Bailey NJC, Johnson HE. Measuring the metabolome:current analytical technologies.Analyst,2005,130(5):606-625.
[28]Monton MRN, Soga T. Metabolome analysis by Capillary Electrophoresis-Mass Spectrometry. Journal of Chromatography A, 2007, 1168: 237-246.
[29]Benneker LM, Heini PF, Alini M. 2004 Young Investigator Award Winner: vertebral endplate marrow contact channel occlusions and intervertebral disc degeneration. Spine. 2005, 30(2): 167-173.
[30]S. R. Bibby, J. P. Urban. Effect of nutrient deprivation on the viability of intervertebral disc cell . Eur. Spine J., 2004, 13, 1369-6701.
[31]D. M. Soukane, S. A. Shirazi-Adl, J. P. Urban. Investigation of solute concentrations in a 3D model of intervertebral disc . Eur. Spine J., 2009, 18, 254-262.
[32]K. R. Keshari, J. C. Lotz, T. M. Link, S. Hu, S. Majumdar and J. Kurhanewicz, Lactic acid and proteoglycans as metabolic markers for discogenic back pain, Spine, 2008, 33(3), 312-317.
[33]Bachmeier BE, Iancu CM, Jochum M, et al. Matrix metalloproteinases in cancer: comparison of known and novel aspects of their inhibition as a therapeutic approach. Expert Rev Anticancer Ther, 2005, 5(1):149-163.
[34]J. E. Heuttner, Glutamate receptor channels in rat DRG neurons: activation by kainite and quisqualate and blockade of desensitization by Con A, Neuron, 1990, 5, 255-267.
[35]M. A. Adams and P. J. Roughley, What is intervertebral disc degeneration, and what causes it, Spine, 2006, 31(18), 2151-2161.
[36]J. F. Harrington, A. A. Messier, D. Bereiter. Herniated lumbar disc material as a source of free glutamate available to affect pain signals through the dorsal rood ganglion. Spine, 2000, 25(8), 929-936.
[37]M. Gårseth, U. Sonnewald, L. R. White. Metabolic changes in the cerebrospinal fluid of patients with lumbar disc herniation or spinal stenosis. Neurosci. Res., 2002, 69(5), 692-695.
[38]H. A. Horner, J. P. Urban. Volvo Award Winner in Basic Science Studies: effect of nutrient supply on the viability of cells from the nucleus pulposus of the intervertebral disc, Spine, 2001, 26, 2543-2549.